description
Powered by Eupheria Biotech
Quality Level
product line
MISSION®
form
lyophilized powder
esiRNA cDNA target sequence
TGCATTCAGCAAATCCAGAGGATCTCTCTCAACACACTGACCCTCAATGTCAAGAGTGAAAAGGTTTATACCCGCCACGGGGTCCCCATCTCAGTCACGGGCATTGCCCAGGTGAAAATCCAGGGCCAGAACAAGGAGATGCTGGCAGCTGCCTGCCAGATGTTCCTGGGGAAGACAGAGGCGGAGATTGCCCACATTGCCCTGGAGACACTGGAAGGCCACCAGAGGGCAATCATGGCCCACATGACTGTGGAGGAGATCTATAAGGATAGACAGAAATTCTCAGAGCAGGTTTTCAAAGTGGCCTCCTCCGACCTGGTCAACATGGGTATCAGCGTGGTTAGCTACACTTTGAAGGATATTCATGATGACCAGGATTACTTACACTCGTTAGGAAAGGCTCG
Ensembl | mouse accession no.
NCBI accession no.
shipped in
ambient
storage temp.
−20°C
Gene Information
mouse ... FLOT1(14251), Flot1(14251)
General description
MISSION® esiRNA are endoribonuclease prepared siRNA. They are a heterogeneous mixture of siRNA that all target the same mRNA sequence. These multiple silencing triggers lead to highly-specific and effective gene silencing.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
For additional details as well as to view all available esiRNA options, please visit SigmaAldrich.com/esiRNA.
Legal Information
MISSION is a registered trademark of Merck KGaA, Darmstadt, Germany
存储类别
10 - Combustible liquids
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Arata Tomiyama et al.
Cancer research, 74(14), 3790-3801 (2014-05-17)
Neuroblastomas harbor mutations in the nonreceptor anaplastic lymphoma kinase (ALK) in 8% to 9% of cases where they serve as oncogenic drivers. Strategies to reduce ALK activity offer clinical interest based on initial findings with ALK kinase inhibitors. In this
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| EMU002671-20UG | 04061831368062 |
| EMU002671-50UG | 04061828429158 |